Evelo Biosciences Inc. (EVLO)
0.00
-0.00 (-100.00%)
At close: Apr 03, 2025, 11:37 AM
-100.00% (1D)
| Bid | n/a |
| Market Cap | 9.49K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -15.64 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 300 |
| Avg. Volume (20D) | 3,853 |
| Open | 0.00 |
| Previous Close | 0.00 |
| Day's Range | 0.00 - 0.00 |
| 52-Week Range | 0.00 - 0.06 |
| Beta | 1.07 |
About EVLO
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also develops EDP1867, an inactivated in...
Industry Biotechnology
Sector Healthcare
IPO Date May 8, 2018
Employees 66
Stock Exchange OTC
Ticker Symbol EVLO
Website https://www.evelobio.com
4 months ago · businesswire.com
EVLO to Provide Dominion Energy With Safety Enhanced Energy Storage SystemsMONTRÉAL--(BUSINESS WIRE)--EVLO Energy Storage Inc. (EVLO), a fully integrated battery energy storage systems (BESS) provider and wholly owned subsidiary of Hydro-Québec, announces a major achievement...